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Management of Chronic Obstructive Pulmonary Disease (COPD) patients involves use of inhaled
steroids, which are known to reduce exacerbations and improve respiratory symptoms. Never-
theless evidence suggests that oral steroids can cause tendonitis, in particular Achilles tendon-
itis and rupture. Here we present a case report of a patient who had moderate COPD confirmed
by spirometry and was started on inhaled steroids. Following this, the patient developed
Achilles tendonitis which was confirmed by ultrasonography and further by reproduction of
symptoms and signs by dechallenge/rechallenge strategy. To our Knowledge, this is the first
report that demonstrates the association of inhaled steroids with tendonitis in COPD patients.
While inhaled steroids might be useful in management of COPD patients; development of
tendonitis as a consequence of this treatment deserves careful thought.
ª 2008 Elsevier Ltd. All rights reserved.Inhaled Corticosteroids are widely prescribed and have an
important role in the management of Chronic obstructive
pulmonary disease (COPD),1 Inhaled steroids have been
shown to decrease the number of exacerbations and reduce
respiratory symptoms in a subgroup of COPD patients. High
dose inhaled corticosteroids have a favorable risk/benefit
ratio in patients with advanced disease, particularly those
with frequent exacerbations, however no proven benefit
has been reported in patients with milder disease.2
Atraumatic Achilles Tendonitis (defined as painful
inflammatory and/or degenerative changes in the Achilles84456111.
goh.nhs.uk (M. Doherty).
ll rights reserved.tendon) is associated with the intake of systemic cortico-
steroids, as well as with fluoroquinolone antibiotics. In
a number of reported cases of achilles tendonitis, oral
steroids were being used for patients with asthma or COPD.
However there is much less evidence of Achilles tendonitis
being associated in patients using inhaled corticosteroids.
Here we present a case of a patient with COPD who
developed Achilles tendonitis on receiving a high dose
inhaled corticosteroids; we present evidence that inhaled
steroids were the cause of this tendonitis.3
Case report
Case: A 69 year old man, a welder by profession, was
referred to the respiratory clinic for assessment of his
16 D. Singh et al.COPD. His past medical history included Abdominal Aorta
Repair, Coronary artery by-pass operation for Ischemic
Heart Disease, Osteoarthritis of both knees and Dyslipide-
mia. His medication included Bisoprolol, salbutamol via
a metred dose inhaler as required, Perindopril, Aspirin,
Simvastatin and Omeprazole.
On assessment in the clinic he had dyspnoea for 10
years, with a decreased exercise tolerance and he had
a number of exacerbations in the last year. He was an ex-
smoker with a smoking history of 80 pack years. Spirom-
etry performed in clinic revealed a forced expiratory
volume (FEV1) of 0.97 l increasing to 1.1 l after 400 mcg
of Salbutamol. On Spirometry he had moderate COPD (as
per NICE Guidelines) with FEV1 of 42% of predicted and an
obstructive pattern with a FEV1/FVC ratio of 52%.
He was started on a maximal inhaled treatment of Sal-
butamol (2 puffs 4 times a day), Tiotropium 18 mcg once
a day, Seretide 500 Accuhaler twice a day (a combination of
fluticasone 500 mcg and Salmeterol 50 mcg). At follow up,
he complained that he had had severe pain in both of his
heels over the area of Achilles Tendons that started two
weeks after starting the Seretide. Therefore he stopped the
statin and the inhaled steroid (Seretide) and the symptoms
resolved completely. On reintroduction of inhaled steroid
the symptoms of tendonitis recurred again after two weeks.
On examination there was some swelling and crepitus felt
over the Achilles Tendons, after which, he was advised to
stop Seretide for the second time, this again resulted in
complete resolution of his symptoms.
Evidence of focal thickening and increased vascularity in
the area of Achilles Tendons was observed on performing an
ultrasound of his tendons; radiologically confirming the
clinical diagnosis of Achilles tendonitis.
Discussion
This patient was appropriately started on high dose inhaled
Corticosteroids combined with a long acting beta agonist,
as his FEV1 was less than 50% predicted and he had
a number of exacerbations in the prior year, this was in line
with the national guidelines.1 In spite of a good safety
profile of Seretide, he developed bilateral Achilles
tendonitis, as a side effect of the drug.
Evidence in literature suggests that patients receiving
high dose of oral steroids can develop Atraumatic Achilles
Tendonitis. Hence, Atraumatic rupture is most prevalent in
patients with rheumatoid arthritis, lupus erythematous,
gout, hyperparathyroidism and chronic renal failure. In
several cases of intermittent use of oral steroids for asthma
and COPD, patients developed achillies tendonitis and in
some cases rupture of the tendon. Histological studies done
using biopsies from Achilles tendon revealed altered fibres
structure and arrangement, focal variations in cellularity,
extracellular glycosaminoglycans, neovascularization, and
hyalinization. However there was no evidence of inflam-
matory cell infiltration.4 Doppler studies have confirmed
the presence of increased vascularity in symptomatic
tendons.5
Evaluation of literature showed that dosage or duration
of steroid use had no correlation with the extent of injury.
Cases of local steroid injections causing Achilles tendonitis
have also been reported. The occurrence of tendonitis withinhaled corticosteroids must however be rare, as to our
knowledge this is the first report in the literature of
Tendonitis occurring in a COPD patient on inhaled Cortico-
steroids without any concomitant systemic steroids.
The clinical diagnosis of tendonitis in this patient was
based on symptoms including pain in calf and over the heel.
Furthermore, dorsiflexion of the ankle increased pain and
tenderness and a tendon friction rub and swelling over the
tendon was palpable. The clinical diagnosis was subse-
quently confirmed by the radiological findings.
According to the Yale algorithm for the assessment of
drug-event association, this patient scored 5 points on the
algorithm.6 Using this algorithm a total score is obtained,
and the score can be used to assign a category to adverse
effects caused by a certain drug. In this case, a score of 5
suggested that causation was highly probable, but not
definite. We believe that the strongest evidence for our
hypothesis that high dose inhaled corticosteroids caused
Achilles tendonitis in this man was obtained by ultrasound
examination of the ankle and the results of the dechal-
lenge/rechallenge strategy.
Seretide is a combination of an inhaled Corticosteroid
and a long acting beta agonist. It could therefore be
possible that the Tendonitis was due to the long acting beta
agonist or due to an interaction between the long acting
beta agonist and the inhaled Corticosteroid. However it is
more likely that the inhaled Corticosteroid was causative
agent, as many different Corticosteroids have already been
associated with Tendonitis. It should be noted that unlike
patients in other reports, this patient was not taking any
systemic corticosteroids or fluoroquinalone antibiotics. Nor
had he taken any of these medications in the 3 months prior
to developing bilateral Tendonitis.
These observations above confirm that inhaled Cortico-
steroids can cause tendonitis in patients with COPD. As
Seretide is commonly prescribed in asthma and COPD, the
development of this side effect must be a very rare event,
as it is not seen in the literature. We think this association
deserves consideration, because of the possible devastating
affects of Tendonitis progressing to Tendon rupture, in
these already debilited patients. While inhaled steroids are
useful in the management of COPD patients; the develop-
ment of tendonitis as a consequence of this treatment
deserves to be brought to clinicians attention.
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